Ledger.Open graph →
SEC Form D · filed January 19, 2018

Braeburn Pharmaceuticals, Inc

Offering
$110.0M
Sold
$110.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PRINCETON, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Brian H. Markison · Princeton, NJDirectorDennis H. Langer, J. D., M.D · Princeton, NJDirectorJeffrey L. Berkowitz · Rye Brook, NYDirectorDavid J. Mcintyre · Princeton, NJExecAsher M. Rubin · Baltimore, MDExecArgeris L. Karabelas, Ph.D · Princeton, NJDirectorPatrick L. Kennedy · Princeton, NJDirectorMichael Derkacz · Princeton, NJExec · DirectorSeth L. Harrison, M.D · Princeton, NJExec · DirectorDennis H. Langer, J. D., M.D · Princeton, NJDirectorJeffrey L. Berkowitz · Princeton, NJDirectorDavid J. Mcintyre · Princeton, NJExecAsher M. Rubin · Baltimore, MDExecBrian H. Markison · Princeton, NJDirectorArgeris L. Karabelas, Ph.D · Princeton, NJDirectorPatrick L. Kennedy · Princeton, NJDirectorMichael Derkacz · Princeton, NJExec · DirectorSeth L. Harrison, M.D · Princeton, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗